Lab Delays Force Maui Grown Therapies to Suspend Sales

By:

SUBJECT TO ACTION BY THE STATE LAB DIVISION, SALES WILL RESUME WEDNESDAY, AUGUST 16

KAHULUI, Hawaii, Aug. 13, 2017 /Weed Wire/ — Hawaiʻi’s first medical cannabis dispensary awaits action by the Hawaiʻi State Labs Division to help unclog a backlog of products so Maui patients can have access to quality assured medicinal cannabis products. The company anticipated its most recent batch of flowers to clear lab certification by today, but that has not happened. Due to high demand, the company sold out its first batch of certified flowers on Saturday. To prevent patients from fruitless trips to its dispensary, the company will close on Monday and Tuesday, August 14 & 15, and reopen on Wednesday, August 16 at noon. Due to uncertain product availability, the company will extend its sales by appointment policy until further notice.

Click here to schedule an appointment.

“It’s unfortunate that an administrative hindrance of this magnitude prevents patients from getting the help they need,” said Christopher Cole, Director of Product Management for Maui Grown Therapies. “We had planned to open with a full range of derivative products such as concentrates, oils, capsules and topical products, but at the eleventh hour we discovered that the State Labs Division had failed to certify a lab to conduct testing of manufactured products.”

Since opening last week Hawaiʻi dispensaries could sell only flowers— resulting in depleted flower stocks on Maui and disappointed patients. “We could serve thousands of patients with the amount of manufactured product we currently have available for final compliance testing,” said Cole. “Even though we were approved by the Department of Health on May 24th to manufacture cannabis products, the restrictions placed on the only licensed lab have prevented us from offering these products to our patients – and it is entirely unclear to us when this will change.”

Maui Grown Therapies co-founder and oncologist Gregory Park, MD is disappointed by the administrative bottleneck from a health perspective. “It’s ironic that our vehemently anti-smoking Department of Health is forcing cannabis patients to smoke to get relief,” he commented.

To better manage sales traffic to match product availability, Maui Grown Therapies will extend its “sales by appointment” policy until further notice. Patients may make a sales appointment through the company’s website: www.mauigrowntherapies.com. Dispensary operating hours have been adjusted to Mon-Sat, noon to 6 pm until further notice. As required by law, Maui Grown Therapies will be closed for Admissions Day on Friday, August 18.

For more information, phone 808-866-7576 or visit www.mauigrowntherapies.com.

Weed Wire disseminates press releases from companies and organizations in the legal marijuana industry. Email weedwire@mjic.com to have your press release added.

Top